Heska

$201.39
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$12.99 (+6.89%) Today
$0.00 (0.00%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell Heska and other stocks, options, and ETFs commission-free!

About HSKA

Heska Corp. engages in the provision of veterinary and animal health diagnostic, and specialty products. It operates through two segments: Core Companion Animal Health and Other Vaccines & Pharmaceuticals. The Core Companion Animal Health segment includes point of care diagnostic laboratory instruments and supplies, imaging instruments, software, and services as well as single use diagnostic and other tests, pharmaceuticals, and vaccines. The Other Vaccines & Pharmaceuticals segment focuses on private label vaccine and pharmaceutical production, primarily for cattle, but also for equine, porcine, avian, feline, and canine. Heska was founded by Robert B. Grieve and Lynnor B. Stevenson in 1988 and is headquartered in Loveland, CO. The listed name for HSKA is Heska Corporation Common Stock.

CEO
Kevin S. Wilson
Employees
386
Headquarters
Loveland, Colorado
Founded
1988
Market Cap
2.10B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
76.15K
High Today
$202.68
Low Today
$189.47
Open Price
$192.07
Volume
59.63K
52 Week High
$217.17
52 Week Low
$50.00

HSKA News

BenzingaFeb 23

Heska: Q4 Earnings Insights

Shares of Heska (NASDAQ:HSKA) were unchanged after the company reported Q4 results. Quarterly Results Earnings per share were up 928.57% over the past year to

HSKA Earnings

-$0.34
$0.01
$0.37
$0.72
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
-$0.22 per share
Actual
$0.72 per share
Replay Earnings Call

You May Also Like

IBTJ
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure